<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>JCAD &#187; Newsletters</title>
	<atom:link href="http://www.jcadonline.com/category/newsletters/feed/" rel="self" type="application/rss+xml" />
	<link>http://www.jcadonline.com</link>
	<description>The Journal of Clinical and Aesthetic Dermatology (JCAD)</description>
	<lastBuildDate>Thu, 19 Jan 2012 16:38:25 +0000</lastBuildDate>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.3.1</generator>
		<item>
		<title>General Considerations and Management Principles in Atopic Dermatitis</title>
		<link>http://www.jcadonline.com/atopic-dermatitis-focus-on-pathogenic-factors-clinical-presentation-and-management-principles/</link>
		<comments>http://www.jcadonline.com/atopic-dermatitis-focus-on-pathogenic-factors-clinical-presentation-and-management-principles/#comments</comments>
		<pubDate>Sun, 01 Aug 2010 17:16:00 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Newsletters]]></category>
		<category><![CDATA[atoopic dermetitis general managment]]></category>
		<category><![CDATA[atopic dermatitis 2011]]></category>
		<category><![CDATA[atopic dermatitis presentation]]></category>
		<category><![CDATA[atopic dermatitis presentations]]></category>
		<category><![CDATA[atopic presentation]]></category>
		<category><![CDATA[cache:ouxa_fhlu7ej:www.jcadonline.com/postinflammatory-hyperpigmentation-a-review-of-the-epidemiology-clinical-features-and-treatment-options-in-skin-of-color/ kligman's formula irritation]]></category>
		<category><![CDATA[cache:ouxa_fhlu7ej:www.jcadonline.com/postinflammatory-hyperpigmentation-a-review-of-the-epidemiology-clinical-features-and-treatment-options-in-skin-of-color/ review postinflammatory hiperpigmentatio]]></category>
		<category><![CDATA[cache:ouxa_fhlu7ej:www.jcadonline.com/postinflammatory-hyperpigmentation-a-review-of-the-epidemiology-clinical-features-and-treatment-options-in-skin-of-color/ undecylenoyl phenylalanine dermatitis]]></category>
		<category><![CDATA[dermatitis presentation]]></category>
		<category><![CDATA[pharmaderm]]></category>
		<category><![CDATA[presentation of atopic dermatitis]]></category>
		<category><![CDATA[principles and general considerations]]></category>
		<category><![CDATA[recent comment:- atopic dermatitis]]></category>

		<guid isPermaLink="false">http://www.jcadonline.com/?p=2780</guid>
		<description><![CDATA[General Considerations and Management Principles in Atopic Dermatitis This newsletter is financially supported by Promius Pharma, LLC. Click &#8220;Full Screen&#8221; below or use slide bar to read full document Dermatology Therapeutic Update: Winter 2011]]></description>
		<wfw:commentRss>http://www.jcadonline.com/atopic-dermatitis-focus-on-pathogenic-factors-clinical-presentation-and-management-principles/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>

